These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7214706)

  • 41. Cranberry does not affect prothrombin time in male subjects on warfarin.
    Li Z; Seeram NP; Carpenter CL; Thames G; Minutti C; Bowerman S
    J Am Diet Assoc; 2006 Dec; 106(12):2057-61. PubMed ID: 17126638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of butabarbital on orally administered anticoagulants.
    Antlitz AM; Tolentino M; Kosai MF
    Curr Ther Res Clin Exp; 1968 Feb; 10(2):70-3. PubMed ID: 4967727
    [No Abstract]   [Full Text] [Related]  

  • 43. Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther MA; Bates SM; Ginsberg JS
    Ann Pharmacother; 2005; 39(7-8):1188-93. PubMed ID: 15914517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin.
    Van Steenbergen W; Vermylen J
    Am J Gastroenterol; 1995 Sep; 90(9):1526-8. PubMed ID: 7661184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose vitamin K to augment anticoagulation control.
    Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
    Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interindividual variability in sensitivity to warfarin--Nature or nurture?
    Loebstein R; Yonath H; Peleg D; Almog S; Rotenberg M; Lubetsky A; Roitelman J; Harats D; Halkin H; Ezra D
    Clin Pharmacol Ther; 2001 Aug; 70(2):159-64. PubMed ID: 11503010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When discharging patients on coumadin, heed this advice.
    Desiato P
    RN; 1996 May; 59(5):10. PubMed ID: 8711315
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitamin K deficiency amplifies anticoagulation response to ximelagatran: possible implications for direct thrombin inhibitors and their clinical safety.
    Kamali F; Wood P; Ward A
    Ann Hematol; 2009 Feb; 88(2):141-9. PubMed ID: 18716776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Green tea can reduce the effect of Waran].
    Al-Aieshy F; Josephson F
    Lakartidningen; 2008 Jun 11-24; 105(24-25):1859. PubMed ID: 18619012
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
    Rao KB; Pallaki M; Tolbert SR; Hornick TR
    Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Warfarin resistance and vitamin K.
    Lee M; Schwartz RN; Sharifi R
    Ann Intern Med; 1981 Jan; 94(1):140-1. PubMed ID: 7447217
    [No Abstract]   [Full Text] [Related]  

  • 55. Enteral feeds may antagonise warfarin.
    Watson AJ; Pegg M; Green JR
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):557. PubMed ID: 6421377
    [No Abstract]   [Full Text] [Related]  

  • 56. Paradoxical effect of vitamin K therapy in aggravating hypoprothrombinaemia.
    Gupta KD; Banerji A
    J Indian Med Assoc; 1967 Nov; 49(10):482-4. PubMed ID: 5594214
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants].
    Costa FV
    Minerva Urol Nefrol; 1988; 40(2 Suppl):5-6. PubMed ID: 2460951
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of patients receiving warfarin sodium (coumadin) therapy with prothrombin time determinations at 3-day intervals.
    ATWOOD WH; MEYER OO
    Am J Med Sci; 1959 Dec; 238():720-6. PubMed ID: 13795014
    [No Abstract]   [Full Text] [Related]  

  • 59. Warfarin resistance associated with nafcillin therapy.
    Fraser GL; Miller M; Kane K
    Am J Med; 1989 Aug; 87(2):237-8. PubMed ID: 2757063
    [No Abstract]   [Full Text] [Related]  

  • 60. Potentiation of anticoagulant effect of coumadin by 5-bromo-2'-deoxyuridine (BUDR).
    Oster SE; Lawrence HJ
    Cancer Chemother Pharmacol; 1988; 22(2):181. PubMed ID: 3409451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.